News | Breast Density | September 12, 2017

Video provides educational resource for underserved yet vulnerable population

DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts

September 12, 2017 – Breast cancer risks associated with fibroglandular breast density are the subject of a new Spanish language video launched recently by DenseBreast-info.org.

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among Hispanic women, a population that is young and growing, yet underserved. During its initial posting on the DenseBreast-info Inc. Spanish language Facebook page, Información Senos Densos, the video garnered over 10,000 views in 72 hours. Currently it is also posted on the organization’s website and is being widely shared within Spanish-speaking communities.

Dense breasts contain a high proportion of glandular compared to fatty tissue. Density can mask cancers on mammography, leading to later-stage diagnoses. Research indicates that cancer detected at the earliest stage possible results in more positive outcomes. Therefore, understanding the implication of dense tissue is particularly important for this population segment. The six-and-a-half-minute video is a primer on breast density, its implications for cancer risk and screening, and appropriate supplemental screening tools.

Breast density notification laws are currently enacted in 30 states, encompassing 70 percent of American women. These laws require that some level of information about breast density be provided to women after their mammogram, but such notification can lead to questions. According to DenseBreast-info chief scientific advisor Wendie Berg, M.D., Ph.D., FACR, “Forty percent of women of mammography age have dense breasts. Breast density can compromise the effectiveness of a mammogram and screening tests such as ultrasound or MRI [magnetic resonance imaging], used in addition to mammography, substantially increase detection of early-stage breast cancer in dense breasts. Additionally, breast density increases a woman’s risk for the disease. Information about personal risk factors and breast cancer screening in dense breasts is important for all women. Patient content in Spanish broadens the reach of this educational resource.”

A Patient Brochure and Patient Risk Checklist are also available in Spanish on the organization’s website.

For more information: www.densebreast-info.org


Related Content

News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Breast Imaging

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that ...

Time May 16, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Breast Imaging

March 04, 2025 — Optellum has entered a strategic agreement with Volpara Health, a Lunit company and a provider of ...

Time March 04, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
Subscribe Now